JP2022514786A5 - - Google Patents
Info
- Publication number
- JP2022514786A5 JP2022514786A5 JP2021536253A JP2021536253A JP2022514786A5 JP 2022514786 A5 JP2022514786 A5 JP 2022514786A5 JP 2021536253 A JP2021536253 A JP 2021536253A JP 2021536253 A JP2021536253 A JP 2021536253A JP 2022514786 A5 JP2022514786 A5 JP 2022514786A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- cdr2
- cdr1
- cdr3
- linker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024181493A JP7882548B2 (ja) | 2018-12-21 | 2024-10-17 | Muc18に特異的な抗体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2018/122572 | 2018-12-21 | ||
| CN2018122572 | 2018-12-21 | ||
| PCT/US2019/067457 WO2020132232A2 (en) | 2018-12-21 | 2019-12-19 | Antibodies specific to muc18 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024181493A Division JP7882548B2 (ja) | 2018-12-21 | 2024-10-17 | Muc18に特異的な抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022514786A JP2022514786A (ja) | 2022-02-15 |
| JP2022514786A5 true JP2022514786A5 (cg-RX-API-DMAC7.html) | 2022-12-16 |
| JP7578289B2 JP7578289B2 (ja) | 2024-11-06 |
Family
ID=71101906
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021536253A Active JP7578289B2 (ja) | 2018-12-21 | 2019-12-19 | Muc18に特異的な抗体 |
| JP2024181493A Active JP7882548B2 (ja) | 2018-12-21 | 2024-10-17 | Muc18に特異的な抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024181493A Active JP7882548B2 (ja) | 2018-12-21 | 2024-10-17 | Muc18に特異的な抗体 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12364770B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3898964A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7578289B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN117343187A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2019401657B2 (cg-RX-API-DMAC7.html) |
| TW (2) | TW202519555A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020132232A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI851634B (zh) | 2018-12-21 | 2024-08-11 | 大陸商沐特圖公司 | Muc18特異性抗體 |
| US20250082777A1 (en) | 2022-01-10 | 2025-03-13 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
| EP4602174A1 (en) | 2022-10-13 | 2025-08-20 | Sana Biotechnology, Inc. | Viral particles targeting hematopoietic stem cells |
| WO2024119157A1 (en) | 2022-12-02 | 2024-06-06 | Sana Biotechnology, Inc. | Lipid particles with cofusogens and methods of producing and using the same |
| AU2024274792A1 (en) | 2023-05-23 | 2025-10-23 | Sana Biotechnology, Inc. | Tandem fusogens and related lipid particles |
| WO2025184529A1 (en) | 2024-03-01 | 2025-09-04 | Sana Biotechnology, Inc. | Viral particles with fusogen display and related compositions and methods |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6824995B1 (en) * | 1998-03-03 | 2004-11-30 | Emory University | Diagnostic for metastatic prostate cancer |
| EP1467756A4 (en) * | 2001-12-28 | 2007-03-21 | Abgenix Inc | METHODS OF USING ANTI-MUC18 ANTIBODIES |
| EP1470146B8 (en) * | 2001-12-28 | 2007-09-12 | Amgen Fremont Inc. | Antibodies against the muc18 antigen |
| CN105732813A (zh) * | 2007-12-18 | 2016-07-06 | 生物联合公司 | 识别癌细胞上表达的cd-43和cea的含糖表位的抗体及其使用方法 |
| CN102936283B (zh) * | 2008-01-31 | 2014-11-05 | 中国科学院生物物理研究所 | 抗人cd146的单克隆抗体,包含其的组合物,检测可溶性cd146的方法 |
| US8679500B2 (en) | 2009-05-14 | 2014-03-25 | Institute National De La Sante Et De La Recherche Medicale (Inserm) | Compositions containing antibodies for treating CD5+ HLA-DR+ B or T cell related diseases |
| TWI595007B (zh) * | 2012-09-10 | 2017-08-11 | Neotope Biosciences Ltd | 抗mcam抗體及相關使用方法 |
| DK3049118T3 (en) * | 2013-09-24 | 2018-08-13 | Oncoinvent As | MONOCLONAL ANTIBODY AND DERIVATIVES |
| PT3116911T (pt) | 2014-03-12 | 2019-09-04 | Prothena Biosciences Ltd | Anticorpos anti-mcam e métodos de utilização associados |
| CN104650231A (zh) * | 2015-02-13 | 2015-05-27 | 南京任诺药业有限公司 | 一种具备高效中和活性的人源化抗人cd146单克隆抗体 |
| WO2017046776A2 (en) * | 2015-09-16 | 2017-03-23 | Prothena Biosciences Limited | Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis |
| WO2017149513A1 (en) * | 2016-03-03 | 2017-09-08 | Prothena Biosciences Limited | Anti-mcam antibodies and associated methods of use |
| WO2018033630A1 (en) | 2016-08-19 | 2018-02-22 | Oncoinvent As | Anti-osteosarcoma car-t derived from the antibody oi-3 |
| WO2018220467A1 (en) | 2017-05-30 | 2018-12-06 | Foroogh Nejatollahi | Anti-muc18 human immunotoxin and applications thereof |
| CN108129567B (zh) | 2018-01-09 | 2019-02-26 | 南京任诺药业有限公司 | 一种具备高效中和活性的人源化抗人cd146单克隆抗体 |
| TWI851634B (zh) | 2018-12-21 | 2024-08-11 | 大陸商沐特圖公司 | Muc18特異性抗體 |
-
2019
- 2019-12-19 WO PCT/US2019/067457 patent/WO2020132232A2/en not_active Ceased
- 2019-12-19 CN CN202311007127.1A patent/CN117343187A/zh active Pending
- 2019-12-19 TW TW113130223A patent/TW202519555A/zh unknown
- 2019-12-19 EP EP19900282.5A patent/EP3898964A4/en active Pending
- 2019-12-19 CN CN201980092138.XA patent/CN113423830B/zh active Active
- 2019-12-19 JP JP2021536253A patent/JP7578289B2/ja active Active
- 2019-12-19 TW TW108146802A patent/TWI855014B/zh active
- 2019-12-19 AU AU2019401657A patent/AU2019401657B2/en active Active
-
2021
- 2021-06-17 US US17/351,014 patent/US12364770B2/en active Active
-
2024
- 2024-10-17 JP JP2024181493A patent/JP7882548B2/ja active Active
-
2025
- 2025-06-16 US US19/239,203 patent/US20250367313A1/en active Pending
- 2025-12-22 AU AU2025283667A patent/AU2025283667A1/en active Pending